INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
HK
Henderson Tracey KExecutive VP Exploration
APAAPA Corp
Option exercise
M—
6,158 sh
Feb 1, 2026Feb 2, 2026
Page 1363 of 1786
← PrevNext →
traded Feb 1, 2026
+1d
SEC Form 4

Evidence

13
TB
Tadele BeimnetEVP & President, Restaurants
VYXNCR Voyix Corp
Tax withholding
F$17K
1,722 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

13
SJ
Sifontes JuanVP, Carlisle Operating System
CSLCARLISLE COMPANIES INC
Tax withholding
F$31K
92 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

13
ES
Evans SharleneDirector
SLPSimulations Plus, Inc.
Grant or award
A—
1,776 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

13
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$44K
218 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$67K
586 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

12
DB
Delco Albert BradEVP & CFO
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$134K
660 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

12
MD
Maddox Mark DExecutive VP - Administration
APAAPA Corp
Tax withholding
F$64K
2,424 sh
Feb 1, 2026Feb 2, 2026
traded Feb 1, 2026
+1dSEC Form 4

Evidence

12
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$50K
444 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

12
PS
Pieper StevenSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$201K
27.3K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

11
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

11
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Tax withholding
F$504K
68.5K sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

11
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Option exercise · 10b5-1 plan
M—
11.3K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

10
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$78K
7,500 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
SN
Steele NicolaChief Operating Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
1,382 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
OP
O'Brien Stephen PaulPrincipal Accounting Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
15.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
WA
Wolfe Adam AEVP, CLO & Chief Admin Officer
UWMCUWM Holdings Corp
Grant or award
A—
175.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
KD
Keefauver DavidEVP of People
JBHTHUNT J B TRANSPORT SERVICES INC
Tax withholding
F$39K
193 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

9
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$13K
111 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
HM
Harris Ivory MarieSVP Chief HR Officer
AGCOAGCO CORP /DE
Tax withholding
F$33K
294 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
CJ
Charlesworth JoshDirector, President & CEO
DNUTKrispy Kreme, Inc.
Grant or award
A—
3,455 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Tax withholding
F$2,948
933 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HR
Hasani RamiEVP, Chief Financial Officer
UWMCUWM Holdings Corp
Grant or award
A—
175.4K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
CL
Contreras Lerdo de Tejada LeonardoDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
400 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
MT
Millwood TimothySVP Chief Supply Chain Officer
AGCOAGCO CORP /DE
Tax withholding
F$34K
296 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
CD
Conn Avi DanielChief Financial Officer
TVRDTvardi Therapeutics, Inc.
Grant or award
A—
45.0K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
DR
Duvivier RaphaelChief Financial Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
1,382 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
GA
Gelfand Jeffrey AdamDirector
NONENONEPIMCO Asset-Based Lending Co LLC
Grant or award
A—
2,811 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
KC
Kale Justin ChristopherSVP CENTRAL STORE OPS & SALES
ORLYO REILLY AUTOMOTIVE INC
Grant or award
A—
3,368 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
VP
Valenzuela Rionda Jose PedroDirector
SCCOSOUTHERN COPPER CORP/
Grant or award
A—
200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
ZT
Zandhuis TerriChief People Officer
DNUTKrispy Kreme, Inc.
Grant or award
A—
2,764 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
10.8K sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
HW
Huddleston Debra WeissDirector
NONENONEPIMCO Asset-Based Lending Co LLC
Grant or award
A—
2,834 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
Thomas RagyDirector
CXMSprinklr, Inc.
Derivative conversion
C—
1,054 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
WP
Wu Cheng-Sheng PeterDirector
CINFCINCINNATI FINANCIAL CORP
Grant or award
A—
847 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
CL
Chi LisaSEE REMARKS
RHRH
Option exercise
M—
6,000 sh
Jan 31, 2026Feb 2, 2026
traded Jan 31, 2026
+2dSEC Form 4

Evidence

9
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Grant or award
A—
168.5K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

9
TJ
Trahan JeremyGeneral Counsel
VMDVIEMED HEALTHCARE, INC.
Option exercise
M—
3,591 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

9
TC
Tarvin Landon CPresident,UFP Retail Solutions
UFPIUFP INDUSTRIES INC
Grant or award
A$1,136
11 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence